[HTML][HTML] Thioredoxin reductase selenoproteins from different organisms as potential drug targets for treatment of human diseases

R Gencheva, Q Cheng, ESJ Arner - Free Radical Biology and Medicine, 2022 - Elsevier
Human thioredoxin reductase (TrxR) is a selenoprotein with a central role in cellular redox
homeostasis, utilizing a highly reactive and solvent-exposed selenocysteine (Sec) residue in …

Thioredoxin signaling pathways in cancer

J Zhang, X Li, Z Zhao, W Cai, J Fang - Antioxidants & Redox …, 2023 - liebertpub.com
Significance: Thioredoxin (Trx) is a powerful antioxidant that reduces protein disulfides to
maintain redox stability in cells and is involved in regulating multiple redox-dependent …

[HTML][HTML] The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1

DM Cheff, C Huang, KC Scholzen, R Gencheva… - Redox biology, 2023 - Elsevier
Ferroptosis is defined as cell death triggered by iron-dependent lipid peroxidation that is
preventable by antioxidant compounds such as ferrostatin-1. Endogenous suppressors of …

[HTML][HTML] NFATc1-mediated expression of SLC7A11 drives sensitivity to TXNRD1 inhibitors in osteoclast precursors

Z Zhong, C Zhang, S Ni, M Ma, X Zhang, W Sang, T Lv… - Redox biology, 2023 - Elsevier
Excess osteoclast activity is found in many bone metabolic diseases, and inhibiting
osteoclast differentiation has proven to be an effective strategy. Here, we revealed that …

Disulfidptosis decoded: a journey through cell death mysteries, regulatory networks, disease paradigms and future directions

J Chen, B Ma, Y Yang, B Wang, J Hao, X Zhou - Biomarker Research, 2024 - Springer
Cell death is an important part of the life cycle, serving as a foundation for both the orderly
development and the maintenance of physiological equilibrium within organisms. This …

[HTML][HTML] Unresolved questions regarding cellular cysteine sources and their possible relationships to ferroptosis

ESJ Arnér, EE Schmidt - Advances in cancer research, 2024 - pmc.ncbi.nlm.nih.gov
Cysteine is required for synthesis of glutathione (GSH), coenzyme A, other sulfur-containing
metabolites, and most proteins. In most cells, cysteine comes from extracellular disulfide …

[HTML][HTML] TXNL1 has dual functions as a redox active thioredoxin-like protein as well as an ATP-and redox-independent chaperone

A Andor, M Mohanraj, ZA Pató, K Úri, B Biri-Kovács… - Redox Biology, 2023 - Elsevier
Abstract TXNL1 (also named TRP32, for thioredoxin related protein of 32 kDa) is a cytosolic
thioredoxin-fold protein expressed in all cell types and conserved from yeast to mammals …

Combined thioredoxin reductase and glutaminase inhibition exerts synergistic anti-tumor activity in MYC-high high-grade serous ovarian carcinoma

PV Raninga, Y He, KK Datta, X Lu, UR Maheshwari… - Molecular Therapy, 2023 - cell.com
Approximately 50%–55% of high-grade serous ovarian carcinoma (HGSOC) patients have
MYC oncogenic pathway activation. Because MYC is not directly targetable, we have …

[HTML][HTML] TrxR1 is involved in the activation of Caspase-11 by regulating the oxidative-reductive status of Trx-1

D Bai, C Zhou, J Du, J Zhao, C Gu, YX Wang, L Zhang… - Redox Biology, 2024 - Elsevier
Sepsis is a common complication of infections that significantly impacts the survival of
critically patients. Currently, effective pharmacological treatment strategies are lacking …

Pro-Oxidant Auranofin and Glutathione-Depleting Combination Unveils Synergistic Lethality in Glioblastoma Cells with Aberrant Epidermal Growth Factor Receptor …

E Martinez-Jaramillo, F Jamali, FH Abdalbari… - Cancers, 2024 - mdpi.com
Simple Summary Glioblastoma (GBM) is a fatal brain cancer. Over 50% of GBM tumors
overexpress EGFR, a protein involved in tumor progression and drug resistance. The …